drugset / Trial / NCT04079062
Single Ascending Dose Study to Assess the Safety, Tolerability, PK and PD of ONO-4685 in Japanese and Caucasian Healthy Adult Male Subjects
RandomizedParallel-groupSingle-blindTreatment
Summary
To investigate safety, tolerability, pharmacokinetics, pharmacodynamics and immunogenicity in Japanese and Caucasian healthy adult male subjects when ONO-4685 is administered as a single-dose by intravenous infusion.
Timeline
- Start
- 2019-09-12
- Primary completion
- 2021-05-25
- Completion
- 2021-05-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ONO-4685 | Unknown | — | Intravenous |
| Subject | keyhole limpet hemocyanin | Vaccine | 1 mg | Subcutaneous |
Indications
No indication recorded.